# Study Investigating Rapamune For Post-Marketing Surveillance

> **NCT00484094** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 209 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** sirolimus

## Key facts

- **NCT ID:** NCT00484094
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2017-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484094, "Study Investigating Rapamune For Post-Marketing Surveillance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00484094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*